North America Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis -By Ulcer Type, Treatment Type, Infection Severity, and End User

Description

List of Tables

The North America diabetic foot ulcer market was valued at US$ 3,570.76 million in 2022 and is expected to reach US$ 5,943.56 million by 2030; it is estimated to grow at a CAGR of 6.6% from 2022 to 2030.

Use of 3D Printing in Wound Care Management Fuels the North America Diabetic Foot Ulcer Market.

Skin tissue damage caused by various indications due to diabetes and vascular diseases significantly burdens the healthcare systems. 3D bioprinting is based on layer-based synthesis, wherein the newly generated cells and cell-based materials can be dispensed to mimic native tissues. Though the technology is still nascent, 3D printing can potentially revolutionize the wound care industry. Many companies are involved in developing new products involving ion-release biomaterials that promote angiogenesis for dermal regeneration. In addition, 3D bioprinting helps patch large wounds that are hard to heal with standard techniques. The use of 3D bioprinting technologies in ulcer or wound treatments is likely to emerge as a prominent trend in the diabetic foot ulcer market in the coming years.

North America Diabetic foot ulcer Market Overview

The North America diabetic foot ulcer market is estimated to grow at a CAGR of 6.64% from 2022 to 2030. Key factors driving the market growth are increasing prevalence of diabetes and related chronic wounds and the rise in geriatric population propel market growth. However, high cost of advanced wound care treatments hinders the market growth. The growing geriatric population in the region also boosts the market growth. According to the Administration on Aging (US Department of Health and Human Services) report published in 2022, there were 55.7 million people aged 65 and above in 2020 in the US. The old age group represents 17% of the population, i.e., 1 in every 6 Americans. As per estimates by the Urban Institute (Washington, DC-based think tank), the number of people aged 65 and older will double over the next 40 years, reaching 80 million in 2040 in the US. Additionally, in 2020, diabetes is regarded as among the leading chronic conditions among adults aged 65 and above.

In recent years, several joint ventures, initiatives, and collaborations contributed to accelerating the diabetic foot ulcers market expansion in North America. For instance, in 2020, six research institutions in the US launched the first-ever multicenter network funded by the National Institutes of Health to study diabetic foot ulcers in the US. Additionally, the Diabetic Foot Canada program was launched in Canada to prevent diabetic foot complications. Thus, the high prevalence of diabetes and the increasing geriatric population will drive the market growth in the region.

North America Diabetic foot ulcer Market Revenue and Forecast to 2030 (US$ Million)

North America Diabetic Foot Ulcer Market Segmentation

Based on treatment type, the North America diabetic foot ulcer market is segmented into advanced wound care dressings, therapy device, and biologics. The advanced wound care dressings segment held largest share in 2022.

Based on ulcer type, the North America diabetic foot ulcer market is segmented into neuro-lschemic ulcers, neuropathic ulcers, and ischemic ulcers. The neuro-lschemic ulcers segment held largest share in 2022.

Based on infection severity, the North America diabetic foot ulcer market is segmented into mild, moderate, and severe. The mild segment held largest share in 2022.

Based on end user, the North America diabetic foot ulcer market is segmented into hospitals, ambulatory surgical centers, and home care. The hospitals segment held largest share in 2022.

Based on country, the North America diabetic foot ulcer market is segmented into US, Canada, and Mexico. The US dominated North America diabetic foot ulcer market in 2022.

Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Medline Industries LP, Organogenesis Inc., Molnlycke Health Care AB, and MiMedx Group Inc are some of the leading companies operating in the North America diabetic foot ulcer market.

Product Code: BMIRE00029570

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Diabetic Foot Ulcer Market Landscape

4.1 Overview

5. North America Diabetic Foot Ulcer Market - Key Industry Dynamics

5.1 Market Drivers:
- 5.1.1 High Prevalence of Diabetes and Related Chronic Wounds
- 5.1.2 Surge in Geriatric Population
5.2 Market Restraints
- 5.2.1 High Cost of Advanced Wound Care Treatments
5.3 Market Opportunities
- 5.3.1 Growing Research Activities to Unveil Novel Wound Treatment Products
5.4 Future Trends
- 5.4.1 Use of 3D Printing in Wound Care Management
5.5 Impact Analysis:

6. Diabetic Foot Ulcer Market - North America Market Analysis

6.1 North America Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 - 2030

7. North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - by Treatment Type

7.1 Overview
7.2 North America Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Advanced Wound Care Dressings
- 7.3.1 Overview
- 7.3.2 Advanced Wound Care Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.3 Alginate Dressings
  - 7.3.3.1 Overview
  - 7.3.3.2 Alginate Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.4 Hydrofiber Dressings
  - 7.3.4.1 Overview
  - 7.3.4.2 Hydrofiber Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.5 Foam Dressings
  - 7.3.5.1 Overview
  - 7.3.5.2 Foam Dressings: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.6 Collagen Dressing
  - 7.3.6.1 Overview
  - 7.3.6.2 Collagen Dressing: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.7 Film Dressing
  - 7.3.7.1 Overview
  - 7.3.7.2 Film Dressing: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.8 Other Dressings
  - 7.3.8.1 Overview
  - 7.3.8.2 Other Dressing: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Biologics
- 7.4.1 Overview
- 7.4.2 Biologics: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 Growth Factors
  - 7.4.3.1 Overview
  - 7.4.3.2 Growth Factors: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 Skin Graft
  - 7.4.4.1 Overview
  - 7.4.4.2 Skin Graft: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Therapy Device
- 7.5.1 Overview
- 7.5.2 Therapy Device: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5.3 Negative Pressure Wound Therapy
  - 7.5.3.1 Overview
  - 7.5.3.2 Negative Pressure Wound Therapy: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5.4 Ultrasound Therapy
  - 7.5.4.1 Overview
  - 7.5.4.2 Ultrasound Therapy: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Ulcer Type

8.1 Overview
8.2 North America Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
8.3 Neuropathic Ulcers
- 8.3.1 Overview
- 8.3.2 Neuropathic Ulcers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Ischemic Ulcers
- 8.4.1 Overview
- 8.4.2 Ischemic Ulcers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Neuro-ischemic Ulcers
- 8.5.1 Overview
- 8.5.2 Neuro-ischemic Ulcers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Infection Severity

9.1 Overview
9.2 North America Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
9.3 Mild, Moderate, and Severe
- 9.3.1 Overview
- 9.3.2 Mild: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 9.3.3 Moderate: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 9.3.4 Severe: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By End User

10.1 Overview
10.2 North America Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
10.3 Hospitals
- 10.3.1 Overview
- 10.3.2 Hospitals: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Ambulatory Surgical Centers
- 10.4.1 Overview
- 10.4.2 Ambulatory Surgical Centers: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Home Care
- 10.5.1 Overview
- 10.5.2 Home Care: North America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

11. Diabetic Foot Ulcer Market - North America Market Analysis

11.1 North America Diabetic Foot Ulcer Market, Revenue and Forecast To 2030
- 11.1.1 Overview
  - 11.1.1.1 North America Diabetic Foot Ulcer Market, by Country
  - 11.1.1.2 US
    - 11.1.1.2.1 US Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.2.2 US Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.2.3 US Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.2.3.1 US: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.2.3.2 US: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.2.3.3 US: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.2.4 US Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.2.5 US Diabetic Foot Ulcer Market, by End User
  - 11.1.1.3 Canada
    - 11.1.1.3.1 Canada Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.3.2 Canada Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.3.3 Canada Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.3.3.1 Canada: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.3.3.2 Canada: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.3.3.3 Canada: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.3.4 Canada Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.3.5 Canada Diabetic Foot Ulcer Market, by End User
  - 11.1.1.4 Mexico
    - 11.1.1.4.1 Mexico Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.4.2 Mexico Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.4.3 Mexico Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.4.3.1 Mexico: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.4.3.2 Mexico: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.4.3.3 Mexico: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.4.4 Mexico Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.4.5 Mexico Diabetic Foot Ulcer Market, by End User

12. North America Diabetic Foot Ulcer Market Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Global Diabetic Foot Ulcer Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. North America Diabetic Foot Ulcer Market - Key Company Profiles

13.1 Convatec Group Plc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 3M Co
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Coloplast AS
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Smith & Nephew Plc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 B. Braun SE
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Molnlycke Health Care AB
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 MiMedx Group Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Medline Industries LP
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Organogenesis Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms